Artelo Biosciences

ARTL · NASDAQ

$2.62−$0.04 (−1.50%)TodayMarket closed · Oct 20, 5:43 PM ET

Prev close $2.66

Latest news

Press releaseOct 7, 8:48 AM ETGlobe Newswire
Artelo Biosciences Selected for its First-Ever Company Presentation at BIO-Europe 2026 to Showcase Clinical Progress and Expanding Potential of its Novel FABP5 Inhibitor Platform
NewsSep 24, 9:43 AM ETAvi Kapoor
Dow Tumbles Over 100 Points; US Jobless Claims Fall to 197,000
NewsSep 23, 1:46 PM ETHenry Khederian
Artelo Biosciences (ARTL) Stock Surges Wednesday: What's Happening?
Press releaseSep 23, 7:33 AM ETGlobe Newswire
Artelo Biosciences Files New Provisional Patent Application Covering ART27.13 for Obesity, Alone and in Combination with GLP-1 Receptor Agonists, Following Unexpected Nonclinical Findings
NewsSep 16, 1:05 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsSep 16, 11:39 AM ETVandana Singh
Artelo Cannabinoid Drug Doubles Weight Loss When Paired with Popular Obesity Drug
Press releaseSep 16, 7:30 AM ETGlobe Newswire
Artelo Biosciences Announces ART27.13 Achieved Weight Loss Comparable to Semaglutide as a Monotherapy and Doubled Weight Loss in Combination with Semaglutide in a Nonclinical Model of Obesity
Press releaseSep 8, 9:00 AM ETGlobe Newswire
Artelo Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Press releaseAug 27, 8:00 AM ETGlobe Newswire
Artelo Biosciences Announces Reverse Stock Split
Press releaseAug 20, 8:52 AM ETGlobe Newswire
Artelo Biosciences Secures Notice of Allowance in Japan for Patent Claims for the Intended Commercial Formulation of ART27.13
Press releaseAug 17, 8:52 AM ETGlobe Newswire
Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies
Press releaseAug 13, 8:00 AM ETGlobe Newswire
Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results
Press releaseAug 10, 8:47 AM ETGlobe Newswire
Artelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma
NewsJul 22, 8:41 AM ET
Artelo Biosciences Announces Publication Of Article 'Evaluating The Pharmacokinetics, Efficacy, And Safety Of Low Dose Cannabidiol' In The British Journal Of Clinical Pharmacology
NewsJul 15, 5:05 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
Press releaseJul 1, 8:42 AM ETGlobe Newswire
Artelo Biosciences Announces New Data Supporting ART26.12 as a Potential First-in-Class Therapy for Chronic Pain associated with Spinal Cord Injury
NewsMay 27, 2:31 PM ETAvi Kapoor
Crude Oil Falls Over 5%; Dycom Industries Shares Surge Following Q1 Results
NewsMay 27, 10:35 AM ETAvi Kapoor
Dow Jumps Over 300 Points; Dick's Sporting Shares Fall After Q1 Results
NewsMay 27, 5:10 AM ETAvi Kapoor
Why Semtech Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
NewsMay 26, 5:06 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
NewsMay 26, 1:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsMay 26, 8:06 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsMay 26, 6:00 AM ETAvi Kapoor
Why JOYY Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
NewsMay 22, 5:05 PM ET
12 Health Care Stocks Moving In Friday's After-Market Session
NewsMay 18, 8:05 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
NewsApr 2, 10:35 AM ETChris Katje
EXCLUSIVE: Top 12 Most-Searched Tickers On Benzinga Pro In March – Where Do Tesla, Nvidia, Micron Stocks Rank?
NewsMar 30, 8:05 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
NewsMar 27, 12:40 PM ETAvi Kapoor
Crude Oil Surges 4%; US Consumer Sentiment Declines In March
NewsMar 27, 10:15 AM ETAvi Kapoor
Dow Tumbles 400 Points; Carnival Shares Fall After Q1 Earnings
NewsMar 26, 1:05 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsMar 26, 8:05 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press releaseMar 25, 4:05 PM ETGlobe Newswire
Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments
NewsMar 25, 8:05 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsMar 24, 1:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsMar 18, 1:06 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsMar 18, 12:04 PM ETAvi Kapoor
Crude Oil Moves Higher; Jabil Shares Slide After Q2 Results
Press releaseMar 18, 10:41 AM ETGlobe Newswire
Biotech Breakthroughs and Strategic Pivots Fuel Market Momentum
NewsMar 18, 9:50 AM ETAvi Kapoor
Dow Falls Over 150 POints; US Producer Prices Increase In February
NewsMar 18, 8:05 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsFeb 24, 7:05 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsFeb 19, 12:05 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsNov 4, 12:06 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsSep 4, 3:06 PM ETAvi Kapoor
Nasdaq Gains Over 100 Points; Science Applications Shares Fall After Q2 Results
NewsSep 4, 12:37 PM ETAvi Kapoor
Dow Surges 200 Points; US Initial Jobless Claims Rise
NewsJun 30, 1:31 PM ETAvi Kapoor
Crude Oil Moves Lower; Joby Aviation Shares Surge
NewsJun 30, 10:30 AM ETAvi Kapoor
Dow Gains Over 100 Points; Chicago PMI Weakens In June
Press releaseAug 13, 8:00 AM ETGlobe Newswire
Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Artelo Biosciences Selected for its First-Ever Company Presentation at BIO-Europe 2026 to Showcase Clinical Progress and Expanding Potential of its Novel FABP5 Inhibitor Platform

Dow Tumbles Over 100 Points; US Jobless Claims Fall to 197,000

Artelo Biosciences (ARTL) Stock Surges Wednesday: What's Happening?

Artelo Biosciences Files New Provisional Patent Application Covering ART27.13 for Obesity, Alone and in Combination with GLP-1 Receptor Agonists, Following Unexpected Nonclinical Findings

12 Health Care Stocks Moving In Wednesday's Intraday Session

Artelo Cannabinoid Drug Doubles Weight Loss When Paired with Popular Obesity Drug

Artelo Biosciences Announces ART27.13 Achieved Weight Loss Comparable to Semaglutide as a Monotherapy and Doubled Weight Loss in Combination with Semaglutide in a Nonclinical Model of Obesity

Artelo Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Artelo Biosciences Announces Reverse Stock Split

Artelo Biosciences Secures Notice of Allowance in Japan for Patent Claims for the Intended Commercial Formulation of ART27.13

Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies

Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results

Artelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma

Artelo Biosciences Announces Publication Of Article 'Evaluating The Pharmacokinetics, Efficacy, And Safety Of Low Dose Cannabidiol' In The British Journal Of Clinical Pharmacology

12 Health Care Stocks Moving In Wednesday's After-Market Session

Artelo Biosciences Announces New Data Supporting ART26.12 as a Potential First-in-Class Therapy for Chronic Pain associated with Spinal Cord Injury

Crude Oil Falls Over 5%; Dycom Industries Shares Surge Following Q1 Results

Dow Jumps Over 300 Points; Dick's Sporting Shares Fall After Q1 Results

Why Semtech Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why JOYY Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Monday's Pre-Market Session

EXCLUSIVE: Top 12 Most-Searched Tickers On Benzinga Pro In March – Where Do Tesla, Nvidia, Micron Stocks Rank?

12 Health Care Stocks Moving In Monday's Pre-Market Session

Crude Oil Surges 4%; US Consumer Sentiment Declines In March

Dow Tumbles 400 Points; Carnival Shares Fall After Q1 Earnings

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

Crude Oil Moves Higher; Jabil Shares Slide After Q2 Results

Biotech Breakthroughs and Strategic Pivots Fuel Market Momentum

Dow Falls Over 150 POints; US Producer Prices Increase In February

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

Nasdaq Gains Over 100 Points; Science Applications Shares Fall After Q2 Results

Dow Surges 200 Points; US Initial Jobless Claims Rise

Crude Oil Moves Lower; Joby Aviation Shares Surge

Dow Gains Over 100 Points; Chicago PMI Weakens In June

Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update